Detalles de la búsqueda
1.
Extended-release methylphenidate for attention deficit hyperactivity disorder (ADHD) in adults.
Cochrane Database Syst Rev
; 2: CD012857, 2022 Feb 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-35201607
2.
Hand cleaning with ash for reducing the spread of viral and bacterial infections: a rapid review.
Cochrane Database Syst Rev
; 4: CD013597, 2020 04 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-32343408
3.
The Cochrane Collaboration withdraws a review on methylphenidate for adults with attention deficit hyperactivity disorder.
Evid Based Med
; 22(4): 143-147, 2017 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-28705922
4.
Pharmacological treatments for generalised anxiety disorder.
Lancet
; 394(10205): 1229, 2019 10 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-31591981
5.
Network meta-analysis of antidepressants.
Lancet
; 392(10152): 1011, 2018 09 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-30264700
6.
Clinical trials were missing from regulatory documents of extended-release methylphenidate for ADHD in adults: a case study of public documents.
J Clin Epidemiol
; 143: 242-253, 2022 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-34752938
7.
EMA and FDA psychiatric drug trial guidelines: assessment of guideline development and trial design recommendations.
Epidemiol Psychiatr Sci
; 30: e35, 2021 Apr 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-33926608
8.
Cross-sectional study of medical advertisements in a national general medical journal: evidence, cost, and safe use of advertised versus comparative drugs.
Res Integr Peer Rev
; 6(1): 8, 2021 May 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-33971984
9.
Considering the methodological limitations in the evidence base of antidepressants for depression: a reanalysis of a network meta-analysis.
BMJ Open
; 9(6): e024886, 2019 06 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-31248914
10.
Medical advertisements and scientific journals: Time for editors and publishers to take a stance.
J Eval Clin Pract
; 29(4): 567-571, 2023 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-36808410
11.
Clinical trials were missing from regulatory documents of extended-release methylphenidate for ADHD in adults: A case study of public documents: author's reply.
J Clin Epidemiol
; 145: 183-184, 2022 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-34936911
12.
The US Food and Drug Administration's authorisation of Purdue's controlled-release methylphenidate for adult ADHD: comments on the regulatory practice.
J R Soc Med
; 114(8): 377-380, 2021 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-33759627
13.
Correction to: Cross-sectional study of medical advertisements in a national general medical journal: evidence, cost, and safe use of advertised versus comparative drugs.
Res Integr Peer Rev
; 6(1): 10, 2021 Jun 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-34116717
14.
Anti-epidermal growth factor receptor siRNA carried by chitosan-transacylated lipid nanocapsules increases sensitivity of glioblastoma cells to temozolomide.
Int J Nanomedicine
; 9: 1479-90, 2014.
Artículo
en Inglés
| MEDLINE | ID: mdl-24711698
15.
Network meta-analysis: the highest level of medical evidence?
BMJ Evid Based Med
; 23(2): 56-59, 2018 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-29595131
16.
Quality of Life of Adult Patients With Attention-Deficit/Hyperactivity Disorder Taking Methylphenidate.
JAMA Psychiatry
; 73(5): 533-4, 2016 05 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-27008275
Resultados
1 -
16
de 16
1
Próxima >
>>